Development of a new contrast agent has potential to take bio-imaging resolution beyond what is currently possible. Image credit: Shutterstock
Scientists using a unique approach have developed a new biomedical imaging contrast agent. They say the breakthrough overcomes a major challenge to “seeing” deeper into live tissue, and opens the way for significant improvements in optical imaging technology.
The development, a result of international collaboration between Fudan University in China and the University of Technology Sydney (UTS), has the potential to take bio-imaging resolution beyond what is currently possible with CT and PET imaging technology. The research is published in Nature Photonics.
Professor Dayong Jin, a senior author on the study and Director of the UTS Institute for Biomedical Materials & Devices (IBMD), said “this outcome is a great example that shows how we transform advances in photonics and material sciences into revolutionary biotechnologies at IBMD”.
Optical contrast agents are used primarily to improve the visualisation and differentiation in tissue and blood vessels in both clinical and research settings.
Read the full story in the Institute for Biomedical Materials and Devices News.